Merck Santé S.A.S., a subsidiary of the global Merck Group, is headquartered in France and operates extensively across Europe and beyond. Founded in the early 20th century, the company has established itself as a leader in the pharmaceutical and life sciences industry, focusing on innovative healthcare solutions. Merck Santé is renowned for its diverse portfolio, which includes prescription medicines, biotechnology products, and cutting-edge research in areas such as oncology, neurology, and fertility. The company’s commitment to scientific excellence and patient-centric approaches sets it apart in a competitive market. With a strong market position, Merck Santé has achieved significant milestones, including advancements in drug development and a robust pipeline of therapies that address unmet medical needs. Its dedication to improving health outcomes continues to drive its success and reputation as a trusted name in healthcare.
How does Merck Santé S.A.S.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Merck Santé S.A.S.'s score of 62 is higher than 50% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Merck Santé S.A.S., headquartered in France, currently does not report specific carbon emissions data for the most recent year, as no emissions figures are available. The company is a current subsidiary of Merck KGaA, which cascades its climate commitments and performance data down to Merck Santé S.A.S. While specific reduction targets or achievements for Merck Santé S.A.S. are not provided, the parent company, Merck KGaA, is known for its commitment to sustainability and has set science-based targets for emissions reductions. These targets are part of a broader strategy to address climate change and reduce carbon footprints across its operations. Merck KGaA's initiatives include participation in the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP), which guide the company in setting ambitious climate goals. However, details on specific targets or performance metrics for Merck Santé S.A.S. are not disclosed. In summary, while Merck Santé S.A.S. does not have specific emissions data or reduction targets available, it is aligned with the sustainability efforts of its parent company, Merck KGaA, which is actively working towards significant climate commitments.
Access structured emissions data, company-specific emission factors, and source documents
2006 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Scope 1 | 352,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 0,000,000,000 | - | - | - | 000,000,000 |
Scope 2 | 402,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | - | - | - | 000,000,000 |
Scope 3 | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 0,000,000,000 | - | - | 0,000,000,000 | 0,000,000,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Merck Santé S.A.S. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.